Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003460231 | SCV004215120 | likely pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-05-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004949105 | SCV005547432 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-09-11 | criteria provided, single submitter | clinical testing | The c.2817delT pathogenic mutation, located in coding exon 9 of the BRCA1 gene, results from a deletion of one nucleotide at nucleotide position 2817, causing a translational frameshift with a predicted alternate stop codon (p.D940Ifs*60). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |